E-ISSN 2231-3206 | ISSN 2320-4672
 

Original Research 


Potential drug-drug interactions among ischemic heart disease patients at a tertiary care hospital

Vijayalakshmi Devarashetty, Praveen A N, Manjunath R.

Abstract
Background: Drug-drug interactions (DDIs) often pose a greatest challenge to health-care providers in patient care, hence their prediction, identification, and prevention are of prime importance.

Aims and Objectives: The aims of the study were to evaluate the potential DDIs (pDDI) and factors influencing clinically relevant pDDI in ischemic heart disease (IHD) patients.

Materials and Methods: An analytical cross-sectional study conducted from April to September 2018 to analyze the pDDIs among the outpatients of the Cardiology Department at Bangalore Medical College and Research Institute. All patients with a history of IHD on at least two drugs were included in the study. Patient demographic data and prescription details (drugs prescribed, duration of therapy, and number of drugs) were collected in a case record form. Drug data were analyzed for interactions using a drug interaction software (Lexicomp version 4.1.1) by risk rating scale (category A, B, C, D, or X).

Results: Of 520 IHD patients, 489 had 3217 pDDIs. The average number of drugs prescribed per patient was 6.41.6 and most commonly prescribed drugs were aspirin (93%), atorvastatin (88%), clopidogrel (60%), metoprolol (57%), and ramipril (43%). Aspirin and clopidogrel (54%), aspirin and ramipril (40%) were the most commonly interacting pairs. The majority of the interactions were of category C, i.e. which requires monitoring of therapy. Number of drugs prescribed and hypertension was found to be the factors significantly influencing clinically relevant pDDIs.

Conclusion: Antiplatelets and statins were the most commonly prescribed drugs in IHD and contributed to most of the pDDIs in particular categories C and D. In addition to number of drugs, comorbidity also influences pDDIs. Awareness regarding DDIs should be raised among prescribers which will enable them to recognize potentially harmful drug combinations and avoid them or to monitor therapy if such drugs are deemed essential.

Key words: Aspirin, Clopidogrel, Ischemic heart disease, Potential drug-drug interactions


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Vijayalakshmi Devarashetty
Articles by Praveen A N
Articles by Manjunath R
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Devarashetty V, N PA, R M. Potential drug-drug interactions among ischemic heart disease patients at a tertiary care hospital. Natl J Physiol Pharm Pharmacol. 2020; 10(7): 557-562. doi:10.5455/njppp.2020.10.12389201926042020


Web Style

Devarashetty V, N PA, R M. Potential drug-drug interactions among ischemic heart disease patients at a tertiary care hospital. http://www.njppp.com/?mno=78269 [Access: October 01, 2020]. doi:10.5455/njppp.2020.10.12389201926042020


AMA (American Medical Association) Style

Devarashetty V, N PA, R M. Potential drug-drug interactions among ischemic heart disease patients at a tertiary care hospital. Natl J Physiol Pharm Pharmacol. 2020; 10(7): 557-562. doi:10.5455/njppp.2020.10.12389201926042020



Vancouver/ICMJE Style

Devarashetty V, N PA, R M. Potential drug-drug interactions among ischemic heart disease patients at a tertiary care hospital. Natl J Physiol Pharm Pharmacol. (2020), [cited October 01, 2020]; 10(7): 557-562. doi:10.5455/njppp.2020.10.12389201926042020



Harvard Style

Devarashetty, V., N, . P. A. & R, . M. (2020) Potential drug-drug interactions among ischemic heart disease patients at a tertiary care hospital. Natl J Physiol Pharm Pharmacol, 10 (7), 557-562. doi:10.5455/njppp.2020.10.12389201926042020



Turabian Style

Devarashetty, Vijayalakshmi, Praveen A N, and Manjunath R. 2020. Potential drug-drug interactions among ischemic heart disease patients at a tertiary care hospital. National Journal of Physiology, Pharmacy and Pharmacology, 10 (7), 557-562. doi:10.5455/njppp.2020.10.12389201926042020



Chicago Style

Devarashetty, Vijayalakshmi, Praveen A N, and Manjunath R. "Potential drug-drug interactions among ischemic heart disease patients at a tertiary care hospital." National Journal of Physiology, Pharmacy and Pharmacology 10 (2020), 557-562. doi:10.5455/njppp.2020.10.12389201926042020



MLA (The Modern Language Association) Style

Devarashetty, Vijayalakshmi, Praveen A N, and Manjunath R. "Potential drug-drug interactions among ischemic heart disease patients at a tertiary care hospital." National Journal of Physiology, Pharmacy and Pharmacology 10.7 (2020), 557-562. Print. doi:10.5455/njppp.2020.10.12389201926042020



APA (American Psychological Association) Style

Devarashetty, V., N, . P. A. & R, . M. (2020) Potential drug-drug interactions among ischemic heart disease patients at a tertiary care hospital. National Journal of Physiology, Pharmacy and Pharmacology, 10 (7), 557-562. doi:10.5455/njppp.2020.10.12389201926042020